JD Health International Inc. Website

JD Health International Inc.

SEHK-6618

Basic

  • Market Cap

    HK$65.54B

  • EV

    HK$20.38B

  • Shares Out

    3,189.47M

  • Revenue

    CN¥53.53B

  • Employees

    3,118

Margins

  • Gross

    22.17%

  • EBITDA

    1.48%

  • Operating

    1.18%

  • Pre-Tax

    5.03%

  • Net

    4%

  • FCF

    8.49%

Returns (5Yr Avg)

  • ROA

    -21.71%

  • ROTA

    -4.13%

  • ROE

    -4.13%

  • ROCE

    0.31%

  • ROIC

    -6.33%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    HK$41.43

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    CN¥41.22B

  • Net Debt

    -CN¥41.01B

  • Debt/Equity

    0

  • EBIT/Interest

    66.51

Growth (CAGR)

  • Rev 3Yr

    40.3%

  • Rev 5Yr

    45.64%

  • Rev 10Yr

  • Dil EPS 3Yr

    -55.67%

  • Dil EPS 5Yr

  • Dil EPS 10Yr

  • Rev Fwd 2Yr

    16.18%

  • EBITDA Fwd 2Yr

    72.19%

  • EPS Fwd 2Yr

    8.21%

  • EPS LT Growth Est

    18.26%

Dividends

  • Yield

  • Payout

  • DPS

  • DPS Growth 3Yr

  • DPS Growth 5Yr

  • DPS Growth 10Yr

  • DPS Growth Fwd 2Yr

Select a metric from the list below to chart it

Dec '17

Dec '18

Dec '19

Dec '20

Dec '21

Dec '22

Dec '23

Dec '24 (E)

Dec '25 (E)

Dec '26 (E)

Total Revenues

10,842.1

19,382.6

30,682.3

46,736.2

53,529.9

Total Revenues % Chg.

32.7%

78.8%

58.3%

52.3%

14.5%

Cost of Goods Sold, Total

8,029.9

14,465.3

23,485

36,844.6

41,664.6

Gross Profit

2,812.3

4,917.3

7,197.3

9,891.5

11,865.3

Selling General & Admin Expenses, Total

2,040.6

3,956.5

7,670.1

8,871.3

9,938.1

Provision for Bad Debts

1.9

0.1

38.4

98.2

69.9

R&D Expenses

338.2

609.1

892.9

1,067.2

1,226.5

Other Operating Expenses, Total

2,380.7

4,565.7

8,601.3

10,036.6

11,234.5

Operating Income

431.6

351.6

-1,404

-145.1

630.8

Interest Expense, Total

-35.5

-3.4

-6

-9.1

-9.5

Interest And Investment Income

31.8

149.1

457.6

864.3

1,949

Net Interest Expenses

-3.7

145.7

451.6

855.2

1,939.5

Income (Loss) On Equity Invest.

-77

-94.2

-96.8

-70.8

Other Non Operating Income (Expenses)

-1,262.6

-17,492.4

145.1

82.5

193.7

EBT, Excl. Unusual Items

-834.7

-17,072.1

-901.5

695.8

2,693.3

EBT, Incl. Unusual Items

-834.7

-17,072.1

-901.5

695.8

2,693.3

Income Tax Expense

137.1

162.8

171.3

312.6

550.5

Earnings From Continuing Operations

-971.8

-17,234.9

-1,072.8

383.2

2,142.9

Minority Interest

0.5

-0.7

-3.1

-1

Net Income

-971.8

-17,234.4

-1,073.5

380.1

2,141.8

Net Income to Common Incl Extra Items

-971.8

-17,234.4

-1,073.5

380.1

2,141.8

Net Income to Common Excl. Extra Items

-971.8

-17,234.4

-1,073.5

380.1

2,141.8

Total Shares Outstanding

2,149.3

3,184.4

3,098.1

3,106.2

3,127.2

Weighted Avg. Shares Outstanding

2,149.3

2,208.5

3,094.9

3,106.9

3,123.7

Weighted Avg. Shares Outstanding Dil

2,149.3

2,208.5

3,094.9

3,144.4

3,164

EPS

-0.5

-7.8

-0.3

0.1

0.7

EPS Diluted

-0.5

-7.8

-0.4

0.1

0.7

EBITDA

436.9

364.5

-1,371.6

-60.9

794.9

Effective Tax Rate

-16.4%

-1%

-19%

44.9%

20.4%